Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Staggering Spots to Stargaze All over the Planet - 2The most effective method to Go with Informed Choices on Vehicle Leases
- 3Instructions to Adjust Work, Life, and Seeking after a Web based Advertising Degree
- 4Investigating the Financial History of the World: A Succinct Outline
- 5They died 'doing what they loved': The stories of workers in their 80s who died on the job
- South Carolina's measles outbreak reaches 434 cases
- Most loved Occasion Dish: What Makes Your Merry Table?
- Great DSLR Cameras for Photography Devotees
- Rick Steves Recommends This German Town's Castle Hotel With Rhine River Views
- Electric discovery on Mars! Scientists find tiny lightning bolts coming from Red Planet dust clouds
- The most effective method to Pick the Right Material Organization: Your Definitive Aide
- Step in Style: A Survey of \Solace and Execution on the Track\ Running Shoes
- Scientists solve the mystery of the prehistoric 'Burtele Foot'
- What's your #1 tone
